Cargando…
p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast
BACKGROUND: p53 is a tumor suppressor that is frequently mutated in human cancers. Although alterations in p53 are common in breast cancer, few studies have specifically investigated TP53 mutations in the breast cancer subtype invasive lobular carcinoma (ILC). Recently reported conditional mouse mod...
Autores principales: | Ercan, Cigdem, van Diest, Paul J., van der Ende, Bram, Hinrichs, John, Bult, Peter, Buerger, Horst, van der Wall, Elsken, Derksen, Patrick W. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306558/ https://www.ncbi.nlm.nih.gov/pubmed/22354696 http://dx.doi.org/10.1007/s13402-012-0071-y |
Ejemplares similares
-
Methylation biomarkers for pleomorphic lobular breast cancer - a short report
por: Moelans, Cathy B., et al.
Publicado: (2015) -
p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice
por: Tenhagen, Milou, et al.
Publicado: (2016) -
Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer
por: Vermeulen, Jeroen F., et al.
Publicado: (2012) -
Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice
por: Derksen, Patrick W. B., et al.
Publicado: (2011) -
Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer
por: Vlug, Eva J., et al.
Publicado: (2013)